Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Qol Holdings Co's share price for the quarter that ended in Dec. 2023 was 円1657. Qol Holdings Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 37 Mil. Therefore, Qol Holdings Co's market cap for the quarter that ended in Dec. 2023 was 円61,790 Mil.
Qol Holdings Co's quarterly market cap
increased
from Jun. 2023 (円64,301 Mil) to Sep. 2023 (円68,941 Mil) but then
declined
from Sep. 2023 (円68,941 Mil) to Dec. 2023 (円61,790 Mil).
Qol Holdings Co's annual market cap
declined
from Mar. 2021 (円56,967 Mil) to Mar. 2022 (円42,999 Mil) but then
increased
from Mar. 2022 (円42,999 Mil) to Mar. 2023 (円43,102 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Qol Holdings Co's Enterprise Value for Today is 円62,052 Mil.
Qol Holdings Co Market Cap Historical Data
The historical data trend for Qol Holdings Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Qol Holdings Co's Market Cap
For the Pharmaceutical Retailers subindustry, Qol Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qol Holdings Co's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Qol Holdings Co's Market Cap falls into.
Qol Holdings Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Qol Holdings Co's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co (TSE:3034) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Qol Holdings Co Market Cap Related Terms
Thank you for viewing the detailed overview of Qol Holdings Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:3034 has been successfully added to your 